Company profile

Eton Pharmaceuticals, Inc. Insider Trading

ETON

Every SEC Form 4 insider trading filing for Eton Pharmaceuticals, Inc. (ETON) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
CIK
0001710340
Filings
55
Insiders
10
Last filing
2026-08-20

Activity summary

Recent insider activity is bullish. Over the last 30 days, 8 insiders purchased shares versus 4 sales. Buying was led by Maier Paul V.

Three year balance

Buy and sell value by quarter, Q1 24 to Q3 26. Eton Pharmaceuticals, Inc. insiders are net sellers across the period shown.

Q1 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $11.9M.

90 day insight

Over the last 90 days, Eton Pharmaceuticals, Inc. insiders bought $558K (25 transactions) and sold $19.2M (16 transactions).

  • Most active insider: Krempa David with 14 transactions totaling $1.9M.
  • Largest single sale: $3.8M by Brynjelsen Sean on May 28, 2026.

Activity skews bullish — buys outpace sales.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Aug 20, 2026Brynjelsen SeanETON
Sale
47,307$60.17$2.85M
Aug 20, 2026Brynjelsen SeanETON
Sale
36,373$61.11$2.22M
Aug 20, 2026Brynjelsen SeanETON
Sale
7,342$62.12$456K
Aug 19, 2026Brynjelsen SeanETON
Sale
8,978$62.65$562K
Jul 31, 2026Maier Paul VETON
Award
10,000

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=ETON" \
  -H "X-Api-Key: $KEY"
Get a key

Top insiders

By total value filed.

Brynjelsen SeanPresident & CEO7 filings$9.6M
Opaleye Management Inc.10% owner7 filings$5.8M
Krempa DavidChief Business Officer10 filings$3.0M
Adams Jennifer McKieDirector2 filings$1.4M
Riedel Norbert GDirector2 filings+$261K

Institutional Ownership

Top 13F-HR holders of Eton Pharmaceuticals, Inc. as of 2026-06-30

↓ decreasing
Total reported AUM
$146.7M
QoQ change
-65.2%
Reporting period
2026-06-30
#1
BlackRock, Inc.
CIK 0002012383
$39.2M
1.1M shares
#2
State Street Corp
CIK 0000093751
$25.4M
702K shares
#3
BlackRock, Inc.
CIK 0002012383
$22.7M
627K shares

Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →